Barber MRW, Drenkard C, Falasinnu T, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17:515–32. https://doi.org/10.1038/s41584-021-00668-1.

Article  PubMed  PubMed Central  Google Scholar 

Kane BS, Niasse M, Ndiaye AA, et al. Systemic diseases in Dakar (Senegal): spectrum, epidemiological aspect and diagnostic time-limit. Open J Intern Med. 2018;08:196–206. https://doi.org/10.4236/ojim.2018.83019.

Article  Google Scholar 

Grennan DM, Bossingham D. Systemic lupus erythematosus (SLE): different prevalences in different populations of Australian aboriginals. Aust N Z J Med. 1995;25:182–3. https://doi.org/10.1111/j.1445-5994.1995.tb02843.x.

Article  CAS  PubMed  Google Scholar 

Magro R, Borg AA. Characterisation of patients with systemic lupus erythematosus in Malta: a population based cohort cross-sectional study. BioMed Res Int. 2018;2018:2385386. https://doi.org/10.1155/2018/2385386.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anstey NM, Bastian I, Dunckley H, Currie BJ. Systemic lupus erythematosus in Australian aborigines: high prevalence, morbidity and mortality. Aust N Z J Med. 1993;23:646–51. https://doi.org/10.1111/j.1445-5994.1993.tb04720.x.

Article  CAS  PubMed  Google Scholar 

Tan G, Baby B, Zhou Y, Wu T. Emerging molecular markers towards potential diagnostic panels for lupus. Front Immunol. 2021;12:808839. https://doi.org/10.3389/fimmu.2021.808839.

Article  CAS  PubMed  Google Scholar 

Nossent J, Kiss E, Rozman B, et al. Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus. Lupus. 2010;19:949–56. https://doi.org/10.1177/0961203310366572.

Article  CAS  PubMed  Google Scholar 

Katsuyama T, Tsokos GC, Moulton VR. Aberrant T cell signaling and subsets in systemic lupus erythematosus. Front Immunol. 2018;9:1088. https://doi.org/10.3389/fimmu.2018.01088.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karrar S, Cunninghame Graham DS. Abnormal B cell development in systemic lupus erythematosus. Arthritis Rheumatol. 2018;70:496–507. https://doi.org/10.1002/art.40396.

Article  PubMed  PubMed Central  Google Scholar 

Yu H, Nagafuchi Y, Fujio K. Clinical and immunological biomarkers for systemic lupus erythematosus. Biomolecules. 2021;11:928. https://doi.org/10.3390/biom11070928.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang W, Yue C, Gao S, et al. Promising roles of exosomal microRNAs in systemic lupus erythematosus. Front Immunol. 2021;12:757096. https://doi.org/10.3389/fimmu.2021.757096.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hong SM, Liu C, Yin Z, Wu L, Qu B, Shen N. MicroRNAs in systemic lupus erythematosus: a perspective on the path from biological discoveries to clinical practice. Curr Rheumatol Rep. 2020;22:17. https://doi.org/10.1007/s11926-020-00895-7.

Article  CAS  PubMed  Google Scholar 

Zhang L, Wu H, Zhao M, Chang C, Lu Q. Clinical significance of miRNAs in autoimmunity. J Autoimmun. 2020;109:102438. https://doi.org/10.1016/j.jaut.2020.102438.

Article  CAS  PubMed  Google Scholar 

Kai K, Dittmar RL, Sen S. Secretory microRNAs as biomarkers of cancer. Semin Cell Dev Biol. 2018;78:22–36. https://doi.org/10.1016/j.semcdb.2017.12.011.

Article  CAS  PubMed  Google Scholar 

O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9:402. https://doi.org/10.3389/fendo.2018.00402.

Article  Google Scholar 

Pal AS, Kasinski AL. Animal models to study microRNA function. Adv Cancer Res. 2017;135:53–118. https://doi.org/10.1016/bs.acr.2017.06.006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Condrat CE, Thompson DC, Barbu MG, et al. miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis. Cells. 2020;9:276.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lopez-Pedrera C, Barbarroja N, Patiño-Trives AM, et al. Role of microRNAs in the development of cardiovascular disease in systemic autoimmune disorders. Int J Mol Sci. 2020;21:2012.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hussein M, Magdy R. MicroRNAs in central nervous system disorders: current advances in pathogenesis and treatment. Egypt J Neurol Psychiatry Neurosurg. 2021;57:36. https://doi.org/10.1186/s41983-021-00289-1.

Article  Google Scholar 

Lan H, Lu H, Wang X, Jin H. MicroRNAs as potential biomarkers in cancer: opportunities and challenges. BioMed Res Int. 2015;2015:125094. https://doi.org/10.1155/2015/125094.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Honarpisheh M, Köhler P, von Rauchhaupt E, Lech M. The involvement of MicroRNAs in modulation of innate and adaptive immunity in systemic lupus erythematosus and lupus nephritis. J Immunol Res. 2018;2018:4126106. https://doi.org/10.1155/2018/4126106.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol. 2019;20:5–20. https://doi.org/10.1038/s41580-018-0059-1.

Article  CAS  PubMed  Google Scholar 

Schell SL, Rahman ZSM. miRNA-mediated control of B cell responses in immunity and SLE. Front Immunol. 2021;12: 683710. https://doi.org/10.3389/fimmu.2021.683710.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chi SW, Zang JB, Mele A, Darnell RB. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature. 2009;460:479–86. https://doi.org/10.1038/nature08170.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cel. 2005;120:15–20. https://doi.org/10.1016/j.cell.2004.12.035.

Article  CAS  Google Scholar 

Lee I, Ajay SS, Yook JI, et al. New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites. Genome Res. 2009;19:1175–83. https://doi.org/10.1101/gr.089367.108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Denzler R, McGeary SE, Title AC, Agarwal V, Bartel DP, Stoffel M. Impact of MicroRNA levels, target-site complementarity, and cooperativity on competing endogenous RNA-regulated gene expression. Mol Cell. 2016;64:565–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129:1401–14. https://doi.org/10.1016/j.cell.2007.04.040.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hsin JP, Lu Y, Loeb GB, Leslie CS, Rudensky AY. The effect of cellular context on miR-155-mediated gene regulation in four major immune cell types. Nat Immunol. 2018;19:1137–45. https://doi.org/10.1038/s41590-018-0208-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carlsen AL, Schetter AJ, Nielsen CT, et al. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 2013;65:1324–34. https://doi.org/10.1002/art.37890.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo X, Tsai LM, Shen N, Yu D. Evidence for microRNA-mediated regulation in rheumatic diseases. Ann Rheum Dis. 2010;1:30–6. https://doi.org/10.1136/ard.2009.117218.

Article  CAS  Google Scholar 

Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int. 2009;29:749–54. https://doi.org/10.1007/s00296-008-0758-6.

Article  CAS  PubMed  Google Scholar 

Te JL, Dozmorov IM, Guthridge JM, et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS ONE. 2010;5:10344. https://doi.org/10.1371/journal.pone.0010344.

Article  CAS  Google Scholar 

Zhang X, Yao B, Hu Q, et al. Detection of biomarkers in body fluids using bioprobes based on aggregation-induced emission fluorogens. Mater Chem Front. 2010;4:2548–70. https://doi.org/10.1039/D0QM00376J.